Vascutek, Ltd. Recalls Gelsoft Plus and Gelweave Vascular Devices Due to Incorrect Shelf Life Labeling
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Vascutek, Ltd. is recalling over 37,000 Gelsoft Plus and Gelweave vascular prostheses because they were labeled with an incorrect expiration date, extending the shelf life by one month.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 3, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Vascutek, Ltd. has initiated a voluntary recall of gelatin-sealed woven polyester prostheses used for vascular repair. The devices were incorrectly labeled with an additional month of shelf life. According to the manufacturer, the device expiry should have been calculated from the date of gel impregnation (the date of manufacture); however, it was incorrectly calculated from the date of device packaging.
Which Products Are Affected
This recall affects approximately 37,430 units distributed nationwide across the United States. Affected products include various models of the following brands:
- Gelsoft Plus: Includes any item number ending in 'E-B' (e.g., 631206PE-B). Specific REF numbers include 635024PE, 631514PE, 631222PE, 633008PE, 633010PE, 633007PE, 636010PE, 632522PE, 633012PE, 635018PE, and others listed in the official recall notice.
- Gelweave: Includes any item number ending in 'E-B' (e.g., 7320128/10RMEE-B). Specific REF numbers include 736038E, 736036E, 736034E, 736032ST/10DE, 736032E, 736030ST/10DE, 736030E, 736028ST/10DE, 736028E, and many others.
Recall Number: Z-1492-2026
Distribution Scope: Nationwide distribution including FL, PA, TX, NC, NY, CA, NJ, OH, MI, DC, CO, VA, GA, IL, OR, ND, VT, MS, MA, IN, WA, AZ, MN, MD, IA, OK, MO, AL, WI, LA, AR, TN, CT, ME, NE, SC, KS, NV, KY, RI, WV, UT, MT, ID, AK, NH, DE, NM, SD, HI, and WY.
What You Should Do
Vascutek, Ltd. initiated the recall by sending notification letters to affected customers. Healthcare providers and facilities should immediately review their inventory for the affected REF and item numbers. If you have these products in stock, follow the specific instructions provided in the manufacturer's letter regarding the return or disposal of the devices.
Why This Matters
The significance of this recall lies in the potential for devices to be used beyond their validated stability period. Incorrect shelf life labeling can lead to the use of prostheses that may not perform as intended during critical vascular repair procedures.
Source
FDA - Recall Event ID: 98338
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category